Home > Drugs A-Z > Gelusil

Gelusil (WellSpring Pharmaceutical Corporation)

Available Formats

Dosage Form Package Information Links
TABLET, CHEWABLE 10 BLISTER PACK in 1 CARTON (65197-300-10) > 10 TABLET, CHEWABLE in 1 BLISTER PACK Label Information
TABLET, CHEWABLE 10 BLISTER PACK in 1 CARTON (65197-300-10) > 10 TABLET, CHEWABLE in 1 BLISTER PACK Label Information
TABLET, CHEWABLE 2 BLISTER PACK in 1 CARTON (65197-300-20) > 10 TABLET, CHEWABLE in 1 BLISTER PACK Label Information
TABLET, CHEWABLE 2 BLISTER PACK in 1 CARTON (65197-300-20) > 10 TABLET, CHEWABLE in 1 BLISTER PACK Label Information

Complete Gelusil Information

  • Active Ingredients (in each tablet)  

    Aluminum hydroxide dried gel 200 mg
    Magnesium hydroxide 200 mg
    Simethicone 25 mg


  • Purpose

    Active ingredients (in each tablet)                  Purpose
    Aluminum hydroxide dried gel 200 mg........................Antacid
    Magnesium hydroxide 200 mg....................................Antacid
    Simethicone 25 mg......................................................Antigas


  • Uses

    Relieves:

    • heartburn
    • sour stomach
    • acid indigestion
    • bloating, pressure and discomfort commonly referred to as gas

  • Warnings

    Ask a doctor before use if you have
    • Kidney disease
    • A magnesium restricted diet

    Ask a doctor or pharmacist before use if you are

    now taking a prescription drug.  Antacids may interact with certain prescription drugs.

    Stop use and ask a doctor if

    symptoms last more than 2 weeks

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away 1.800.222.1222

    If pregnant or breastfeeding

     ask a health professional before use.


  • Directions

    • For adults and children 12 years of age and older: Chew 2 to 4 tablets.  Repeat hourly if symptoms return, or as directed by a physician
    • Do not take more than 12 tablets in a 24-hour period, or use the maximum dosage for more than 2 weeks, except under the advice and supervision of a physician
    • Children under 12: ask a doctor

  • Other information

    • Each tablet contains: magnesium 95 mg
    • Store at 59º to 77º (15º to 25ºC)
    • Tamper Evident. Do not use if blister or printed Gelusil foil seal is broken
    • See send panel for lot number and expiration date

  • Inactive ingredients

    Dextrose, flavors, magnesium stearate, maltodextrin, silica, sucralose


  • Questions?

    Call 1-844-241-5454


  • SPL UNCLASSIFIED SECTION

    © WellSpring 2016
    Sarasota, FL 34243 USA
    Made in USA


  • Principal display panel - Carton

     Raritan Carton


  • INGREDIENTS AND APPEARANCE
    GELUSIL 
    alumina, magnesia, simethicone tablet, chewable
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:65197-300
    Route of Administration ORAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) (ALUMINUM HYDROXIDE - UNII:5QB0T2IUN0) ALUMINUM HYDROXIDE 200 mg
    MAGNESIUM HYDROXIDE (UNII: NBZ3QY004S) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM HYDROXIDE 200 mg
    DIMETHICONE (UNII: 92RU3N3Y1O) (DIMETHICONE - UNII:92RU3N3Y1O) DIMETHICONE 24 mg
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4) (SILICON DIOXIDE - UNII:ETJ7Z6XBU4) SILICON DIOXIDE 1 mg
    Inactive Ingredients
    Ingredient Name Strength
    DEXTROSE (UNII: IY9XDZ35W2)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    SUCRALOSE (UNII: 96K6UQ3ZD4)  
    SILICON (UNII: Z4152N8IUI)  
    Product Characteristics
    Color WHITE Score no score
    Shape ROUND Size 16mm
    Flavor PEPPERMINT Imprint Code PD;GELUSIL;034
    Contains     
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:65197-300-10 10 in 1 CARTON 09/24/2008
    1 10 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH FINAL part331 09/24/2008
    Labeler - WellSpring Pharmaceutical Corporation (110999054)